Viewing Study NCT00287157


Ignite Creation Date: 2025-12-24 @ 6:32 PM
Ignite Modification Date: 2026-03-17 @ 11:45 PM
Study NCT ID: NCT00287157
Status: COMPLETED
Last Update Posted: 2009-01-21
First Post: 2006-02-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic Traumatic Brain Injury (TBI)
Sponsor: Teva GTC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module